← Leaderboards
Haesuk Park
University Of Florida
$2,751,345
Attributed
$2,751,345
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $735.9K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,751,345 · 2
By mechanism
R01$2,102,922 · 1
K01$648,423 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Chen Liu$8,980,679
- David R Nelson$45,053,283
- Andrew J. Muir$3,704,943
- George Louis Drusano$18,475,919
- Ashley Brown$2,797,681
Others in their field
Other Emerging Leaders on “Substance Use Disorder”
- Susan M Landau · University Of California Berkeley$47,252,026
- Timothy M Willson · University Of Cape Town$32,741,597
- Rene S. Kahn · Icahn School Of Medicine At Mount Sinai$13,629,024
- Richard Scranton · Lyndra Therapeutics, Inc.$12,106,230
- Xinhua Li · Nano Terra, Inc.$11,962,715
- Eve Jelstrom · The Emmes Company, Llc$11,930,824
Research focus
Substance Use DisorderHepatitis CCo-InfectionUniversitiesHepatitis C VirusFloridaLinkInjection Drug UseAdultHepatitis C TransmissionDesignDisease ProgressionPhysiciansRisk FactorsClinical PracticeMortalityEffectivenessMorbidity - Disease RatePersonsRouteChronic Hepatitis CHepatitis C TherapyInsightCollege
Grant awards (9)
Assessing performance of a Hepatitis C Emergency Department (HepC-END) Screening Tool$664,679
R01 · FY2025 · DA · contact PI
Assessing performance of a Hepatitis C Emergency Department (HepC-END) Screening Tool$651,976
R01 · FY2024 · DA · contact PI
Social determinants of health for predicting risks of HCV infection and HCV/HIV co-infection$83,880
R01 · FY2024 · DA · contact PI
Assessing performance of a Hepatitis C Emergency Department (HepC-END) Screening Tool$702,387
R01 · FY2023 · DA · contact PI
Medicaid Prior Authorization Policies for Chronic Hepatitis C Treatment in Vulnerable Populations$130,094
K01 · FY2022 · DA · contact PI
Medicaid Prior Authorization Policies for Chronic Hepatitis C Treatment in Vulnerable Populations$128,961
K01 · FY2021 · DA · contact PI
Medicaid Prior Authorization Policies for Chronic Hepatitis C Treatment in Vulnerable Populations$129,252
K01 · FY2020 · DA · contact PI
Medicaid Prior Authorization Policies for Chronic Hepatitis C Treatment in Vulnerable Populations$130,075
K01 · FY2019 · DA · contact PI
Medicaid Prior Authorization Policies for Chronic Hepatitis C Treatment in Vulnerable Populations$130,041
K01 · FY2018 · DA · contact PI